Utilization of sperm banking and barriers to its use in testicular cancer patients
- 15 February 2015
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 23 (9) , 2763-2768
Abstract
Testicular cancer is the most common carcinoma in 20- to 40-year-old men. Eighty percent of patients with metastases achieve disease-free status with chemotherapy with or without surgical resection. Standard first-line chemotherapy is bleomycin, etoposide, and cisplatin (BEP) for three to four courses or etoposide and cisplatin (EP) for four courses. Forty percent of patients receiving chemotherapy will have permanently reduced sperm counts impairing future fertility. Sperm banking is an effective method of maintaining fertility. This retrospective study was performed to assess utilization and results from sperm banking, as well as the barriers to its use.Keywords
This publication has 15 references indexed in Scilit:
- Sperm banking for fertility preservation: a 20-year experienceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Barriers to Fertility Preservation in Male Adolescents With Cancer: It's Time for a Multidisciplinary Approach that Includes UrologistsUrology, 2012
- Testicular function and fertility preservation in male cancer patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Fertility in patients treated for testicular cancerJournal of Cancer Survivorship, 2010
- Effectiveness of sperm banking in adolescents and young adults with cancerCancer, 2007
- American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer PatientsJournal of Clinical Oncology, 2006
- Twenty Years Experience with Semen Cryopreservation in Testicular Cancer Patients: Who Needs It?European Urology, 2005
- Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumorsCancer, 2003
- Gonadal Function of Patients Treated With Cisplatin Based Chemotherapy for Germ Cell CancerJournal of Urology, 1997
- Gonadal Function of Patients Treated With Cisplatin Based Chemotherapy for Germ Cell CancerJournal of Urology, 1997